Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study

2012 ◽  
Vol 25 (5) ◽  
pp. 782-788 ◽  
Author(s):  
Stéphanie Belaiche ◽  
Thierry Romanet ◽  
Benoît Allenet ◽  
Jean Calop ◽  
Philippe Zaoui
2007 ◽  
Vol 85 (1) ◽  
pp. 96-101 ◽  
Author(s):  
Christelle Raffaitin ◽  
Catherine Lasseur ◽  
Philippe Chauveau ◽  
Nicole Barthe ◽  
Henri Gin ◽  
...  

2014 ◽  
Vol 29 (12) ◽  
pp. 2293-2302 ◽  
Author(s):  
Rajiv Agarwal ◽  
Kevin L. Duffin ◽  
Dennis A. Laska ◽  
James R. Voelker ◽  
Matthew D. Breyer ◽  
...  

2022 ◽  
Author(s):  
Yuemiao Zhang ◽  
Xingzi Liu ◽  
Miaomiao Lin ◽  
Jincan Zan ◽  
Yitong Hu ◽  
...  

Patients with chronic kidney disease (CKD) are at higher risk for coronavirus disease 2019 (COVID-19)-related morbidity and mortality. However, a significant portion of CKD patients showed hesitation toward vaccination in telephone survey of our center. Yet no serial data available on humoral response in patients with CKD, especially those on immunosuppression. We conducted a pilot, prospective study to survey the safety and humoral response to inactivated SARS-CoV-2 vaccine in CKD patients receiving a 2-dose immunization of inactivated SARS-CoV-2 vaccine. We found the neutralizing antibody titers in CKD patients was significantly lower than that in healthy controls, hypertension patients, and diabetes patients. Notably, immunosuppressive medication rather than eGFR levels or disease types showed effect on the reduction of immunogenicity. Interestingly, a third dose significantly boosted neutralizing antibody in CKD patients while immunosuppressants impeded the boosting effects. In conclusion, our data demonstrates that CKD patients, even for those on immunosuppression treatment, can benefit from a third vaccination boost by improving their humoral immunity.


2012 ◽  
Vol 60 (5) ◽  
pp. 877-883 ◽  
Author(s):  
Ellen F. Binder ◽  
Heidi K. White ◽  
Barbara Resnick ◽  
William M. McClellan ◽  
Lei Lei ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Woori Na ◽  
Susan Park ◽  
Cheongmin Sohn

Abstract Objectives Diet is an important determinant of chronic kidney disease (CKD) development. The purpose of this study was to evaluate the association of proportion of dietary protein from plant sources with the risk of incident CKD in a population-based prospective study. The purpose of this study was to evaluate the association of proportion of dietary protein from plant sources with the risk of incident CKD in a population-based prospective study. Methods This study analyzed data from the Health Examinee (HEXA) cohort of the Korean Genome and Epidemiology Study (KoGES) between 2005 and 2012 for 148,534 individuals who were initially free of CKD and aged 40–69 years. Baseline diet was assessed by a validated FFQ. Estimated glomerular filtration rate (eGFR) was calculated, using the CKD–EPI equation, and CKD was defined as eGFR < 60 ml/min per 1.73 m2. Multivariate Cox proportional hazard models were used to examine the risk for incident according to dietary proportion of protein from plant sources. Results The mean of plant protein-total protein ratio was 59.1 ± 13.52%. There were 1041 cases of incident CKD over a median of 6.41 years of follow-up. After adjustment for demographic, clinical and dietary factors, the highest quartile of a proportion of dietary protein from plant sources was significantly associated with the development of incident CKD (HR comparing fourth to first quartile, 0.738; 95%CI, 0.583–0.933) in men, but not in women. Conclusions We observed that a diet with higher proportion of protein from plant sources is associated with decreased risk of incident CKD in men. This study provides evidence suggesting a potential protective effect of plant protein sources against the development of CKD. Funding Sources N/A.


Sign in / Sign up

Export Citation Format

Share Document